iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers

NCT07064564 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Naltrexone implant, 14.4 grams
DRUG: Naltrexone implant, 9.6 grams
DRUG: Extended-release naltrexone injection, 380 mg

Sponsor

Akyso Therapeutics, LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]